Cwm, LLC Repligen Corp Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cwm, LLC holds 428 shares of RGEN stock, worth $61,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

428

Previous 314 36.31%

Holding current value

$61,828

Previous $40,000 60.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$119.79 - $167.35 $13,656 - $19,077	114 Added 36.31%	428 $64,000
Q2 2024 Jul 09, 2024	SELL	$120.0 - $182.95 $5,640 - $8,598	-47 Reduced 13.02%	314 $40,000
Q1 2024 Apr 05, 2024	BUY	$170.78 - $208.42 $10,246 - $12,505	60 Added 19.93%	361 $66,000
Q4 2023 Feb 01, 2024	SELL	$114.17 - $185.35 $10,389 - $16,866	-91 Reduced 23.21%	301 $54,000
Q3 2023 Oct 11, 2023	BUY	$138.78 - $176.51 $1,110 - $1,412	8 Added 2.08%	392 $62,000
Q2 2023 Aug 03, 2023	BUY	$138.42 - $180.31 $8,582 - $11,179	62 Added 19.25%	384 $54,000
Q1 2023 Apr 28, 2023	SELL	$154.26 - $198.1 $8,484 - $10,895	-55 Reduced 14.59%	322 $54,000
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $37,377 - $59,696	233 Added 161.81%	377 $71,000
Q2 2022 Jul 28, 2022	BUY	$140.68 - $188.02 $7,737 - $10,341	55 Added 61.8%	144 $23,000
Q1 2022 Apr 21, 2022	BUY	$161.19 - $257.96 $10,154 - $16,251	63 Added 242.31%	89 $17,000
Q4 2021 Jan 31, 2022	BUY	$247.59 - $304.47 $2,723 - $3,349	11 Added 73.33%	26 $7,000
Q1 2021 Sep 15, 2021	SELL	$180.37 - $226.26 $3,968 - $4,977	-22 Reduced 59.46%	15 $3,000
Q1 2021 Apr 27, 2021	BUY	$180.37 - $226.26 $3,968 - $4,977	22 Added 146.67%	37 $7,000
Q4 2020 Sep 15, 2021	SELL	$148.08 - $206.57 $3,257 - $4,544	-22 Reduced 59.46%	15 $3,000
Q4 2020 Jan 27, 2021	BUY	$148.08 - $206.57 $3,257 - $4,544	22 Added 146.67%	37 $7,000
Q2 2020 Sep 15, 2021	BUY	$94.33 - $140.48 $1,414 - $2,107	15 New	15 $3,000
Q2 2020 Jul 22, 2020	SELL	$94.33 - $140.48 $1,414 - $2,107	-15 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$84.96 - $109.14 $1,274 - $1,637	15 New	15 $3,000
Q1 2020 Apr 28, 2020	SELL	$84.96 - $109.14 $1,274 - $1,637	-15 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$73.84 - $93.08 $1,107 - $1,396	15 New	15 $3,000
Q4 2019 Jan 27, 2020	SELL	$73.84 - $93.08 $1,107 - $1,396	-15 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$76.65 - $95.51 $1,149 - $1,432	15 New	15 $3,000
Q3 2019 Oct 22, 2019	SELL	$76.65 - $95.51 $1,149 - $1,432	-15 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$54.2 - $85.95 $813 - $1,289	15 New	15 $3,000
Q2 2019 Jul 31, 2019	SELL	$54.2 - $85.95 $813 - $1,289	-15 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$49.45 - $62.8 $741 - $942	15 New	15 $0

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account